Literature DB >> 22552985

Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes.

Romain Neugebauer1, Bruce Fireman, Jason A Roy, Patrick J O'Connor, Joe V Selby.   

Abstract

PURPOSE: Chronic disease care typically involves treatment decisions that are frequently adjusted to the patient's evolving clinical course (e.g., hemoglobin A1c monitoring and treatment intensification in diabetes patients). Thus, in comparative effectiveness and safety research (CER), it often is less clinically relevant to contrast the health effects of static treatment decisions than to compare the effectiveness of competing medical guidelines, that is, adaptive treatment strategies that map the patient's unfolding clinical course to subsequent treatment decisions. With longitudinal observational studies, treatment decisions at any point in time may be influenced by clinical factors that also are risk factors for the outcome of interest. Such time-dependent confounders cannot be properly handled with standard statistical approaches, because such confounders may be influenced by previous treatment decisions and may thus lie on causal pathways between the very outcomes and early treatment decisions whose effects are under study. Under explicit assumptions, we motivate the application of inverse probability weighting estimation to fit dynamic marginal structural models (MSMs) in observational studies to address pragmatic CER questions and properly adjust for time-dependent confounding and informative loss to follow-up.
METHODS: We review the principles behind this modeling approach and describe its application in an observational study of type 2 diabetes patients to investigate the comparative effectiveness of four adaptive treatment intensification strategies for glucose control on subsequent development or progression of urinary albumin excretion.
RESULTS: Results indicate a protective effect of more aggressive treatment intensification strategies in patients already on two or more oral agents or basal insulin. These conclusions are concordant with recent randomized trials.
CONCLUSIONS: Inverse probability weighting estimation to fit dynamic MSM is a viable and appealing alternative to inadequate standard modeling approaches in many CER problems where time-dependent confounding and informative loss to follow-up are expected.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552985     DOI: 10.1002/pds.3253

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  13 in total

1.  The Choice of Analytical Strategies in Inverse-Probability-of-Treatment-Weighted Analysis: A Simulation Study.

Authors:  Shibing Yang; Juan Lu; Charles B Eaton; Spencer Harpe; Kate L Lapane
Journal:  Am J Epidemiol       Date:  2015-08-26       Impact factor: 4.897

2.  Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes.

Authors:  Amer M Zeidan; Franklin Hendrick; Erika Friedmann; Maria R Baer; Steven D Gore; Medha Sasane; Carole Paley; Amy J Davidoff
Journal:  J Comp Eff Res       Date:  2015-08       Impact factor: 1.744

Review 3.  Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Authors:  Shibing Yang; Charles B Eaton; Juan Lu; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-24       Impact factor: 2.890

4.  Technology-Enabled Outreach to Patients Taking High-Risk Medications Reduces a Quality Gap in Completion of Clinical Laboratory Testing.

Authors:  Marsha A Raebel; Susan M Shetterly; Bharati Bhardwaja; Andrew T Sterrett; Emily B Schroeder; Joseph Chorny; Tyson P Hagen; David J Silverman; Rex Astles; Ira M Lubin
Journal:  Popul Health Manag       Date:  2019-05-20       Impact factor: 2.459

5.  Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models.

Authors:  Jincheng Shen; Lu Wang; Jeremy M G Taylor
Journal:  Biometrics       Date:  2016-11-28       Impact factor: 2.571

6.  Identifying Preanalytic and Postanalytic Laboratory Quality Gaps Using a Data Warehouse and Structured Multidisciplinary Process.

Authors:  Marsha A Raebel; LeeAnn M Quintana; Emily B Schroeder; Susan M Shetterly; Lisa E Pieper; Paul L Epner; Laura K Bechtel; David H Smith; Andrew T Sterrett; Joseph A Chorny; Ira M Lubin
Journal:  Arch Pathol Lab Med       Date:  2018-12-10       Impact factor: 5.534

7.  A Case Study of the Impact of Data-Adaptive Versus Model-Based Estimation of the Propensity Scores on Causal Inferences from Three Inverse Probability Weighting Estimators.

Authors:  Romain Neugebauer; Julie A Schmittdiel; Mark J van der Laan
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

8.  Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling.

Authors:  Romain Neugebauer; Bruce Fireman; Jason A Roy; Marsha A Raebel; Gregory A Nichols; Patrick J O'Connor
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

9.  Estimating Effects of Dynamic Treatment Strategies in Pharmacoepidemiologic Studies with Time-varying Confounding: A Primer.

Authors:  Xiaojuan Li; Jessica G Young; Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2017-10-17

10.  Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes.

Authors:  Romain Neugebauer; Bruce Fireman; Jason A Roy; Patrick J O'Connor
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.